Metabolomics for genomics: the role of vitamin D in nonalcoholic fatty liver disease

J Gastrointestin Liver Dis. 2015 Sep;24(3):394-5.

Authors

Dana Crisan¹, Corina Radu², Alina Suciu³, Mircea D Grigorescu⁴, Horia Stefanescu⁴, Florina Romanciuc⁵, Carmen Socaciu⁵, Mircea Grigorescu⁴

Affiliations

¹ Iuliu Hatieganu University of Medicine and Pharmacy; Clinical Municipal Hospital, Cluj-Napoca, Romania.
² Iuliu Hatieganu University of Medicine and Pharmacy; Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romamia.
³ Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.md.alinasuciu@gmail.com.
⁴ Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania.
⁵ Faculty of Food Science and Technology, University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca,Romania.

PMID: 26405717

No abstract available

Publication types

Letter

MeSH terms

25-Hydroxyvitamin D3 1-alpha-Hydroxylase / genetics*
Biomarkers / blood
Calcifediol / blood*
Case-Control Studies
Chromatography, High Pressure Liquid
Elasticity Imaging Techniques
Genomics*
Genotype
Humans
Mass Spectrometry
Metabolomics* / methods
Non-alcoholic Fatty Liver Disease / blood*
Non-alcoholic Fatty Liver Disease / diagnosis
Non-alcoholic Fatty Liver Disease / enzymology
Non-alcoholic Fatty Liver Disease / genetics*
Pilot Projects
Polymorphism, Genetic*
Predictive Value of Tests
Principal Component Analysis
Prognosis

Substances

Biomarkers
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
CYP27B1 protein, human
Calcifediol